Active substance
Minoxidil
- SFDA 17
- US FDA 47
- Health Canada 9
- US price lines 3
- NHS prices 6
- Safety 6
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ALOPEXY 5% topical solution | 5 % | Cutaneous solution · Topical | 3 Bottle | SAR 84.25 | Generic · OTC | PIERRE FABRE DERMATOLOGIE | Valid |
| ALOPEXY 5% topical solution | 5 % | Cutaneous solution · Topical | 1 Bottle | SAR 37.40 | Generic · OTC | PIERRE FABRE DERMATOLOGIE | Valid |
| AVOGAIN | 5 % | Cutaneous solution · Topical | 1 Bottle | SAR 66.00 | Generic · OTC | Middle East Pharmaceutical Industries Co Ltd Avalon Pharma | Valid |
| AVOGAIN | 2 % | Cutaneous solution · Topical | 1 Bottle | SAR 55.50 | Generic · OTC | Middle East Pharmaceutical Industries Co Ltd Avalon Pharma | Valid |
| HAIRGAIN 2% W-V SOLUTION FOR WOMEN | 2 % | Solution · Topical | 1 Bottle | SAR 57.75 | Generic · OTC | MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES | Valid |
| HAIRGAIN 5% W-V SOLUTION FOR MEN | 5 % | Solution · Topical | 1 Bottle | SAR 57.75 | Generic · OTC | MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES | Valid |
| HAIRGROW | 5 % | Solution · Topical | 1 Bottle | SAR 59.05 | Generic · OTC | DAR ALDAWA | Valid |
| HAIRGROW | 2 % | Solution · Topical | 1 Bottle | SAR 52.70 | Generic · OTC | DAR ALDAWA | Valid |
| MINOXIL 5% SOLUTION | 5 % | Cutaneous solution · Topical | 1 Bottle | SAR 64.15 | Generic · OTC | Dallah Pharma Factory | Valid |
| Minoxil | 2 % | Solution · Topical | 1 Bottle | SAR 47.75 | Generic · OTC | Dallah Pharma Factory | Valid |
| NEOXIDIL 2% SOLN. | 2 % | Solution · Topical | 1 Bottle | SAR 55.30 | Generic · OTC | GALDERMA | Valid |
| REGAINE 5% TOPICAL SOLUTION | 5 % | Cutaneous solution · Topical | 1 Bottle | SAR 86.35 | Generic · OTC | MCNEIL PRODUCTS LIMITED | Valid |
| REGAINE TOPICAL SOLN 2% | 2 % | Cutaneous solution · Topical | 1 Bottle | SAR 67.65 | NCE · OTC | MCNEIL PRODUCTS LIMITED | Valid |
| Regaine Foam for Men 5% | 5 % | Cutaneous foam · Cutaneous use | 1 AEROSOL CAN | SAR 95.00 | NCE · OTC | MCNEIL PRODUCTS LIMITED | Valid |
| HAIRAL 2% TOPICAL SOLUTION | 2 % | Solution · Topical | 1 Bottle | SAR 31.15 | Generic · OTC | JERASH PHARMACEUTICALS LIMITED COMPANY | Suspended · Not Marketed |
| HAIRAL 5% TOPICAL SOLUTION | 5 % | Solution · Topical | 1 Bottle | SAR 31.15 | Generic · OTC | JERASH PHARMACEUTICALS LIMITED COMPANY | Suspended · Not Marketed |
| REGAINE TOPICAL GEL 2% | 2 % | Gel · Topical | 1 Bottle | SAR 97.15 | Generic · Prescription | PFIZER | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| MINOXIDIL | 2.5MG | tablet · oral | WATSON LABS | Prescription | 3 Mar 1987 |
| MINOXIDIL | 10MG | tablet · oral | WATSON LABS | Prescription | 3 Mar 1987 |
| ROGAINE (FOR MEN) | 2% | solution · topical | KENVUE BRANDS | Over-the-counter | 17 Aug 1988 |
| ROGAINE (FOR WOMEN) | 2% | solution · topical | KENVUE BRANDS | Over-the-counter | 17 Aug 1988 |
| MINOXIDIL | 2.5MG | tablet · oral | PH HEALTH | Prescription | 14 Nov 1988 |
| MINOXIDIL | 10MG | tablet · oral | PH HEALTH | Prescription | 14 Nov 1988 |
| MINOXIDIL | 10MG; 2.5MG | tablet · oral | SUN PHARM INDUSTRIES | Prescription | 13 Dec 1995 |
| MINOXIDIL (FOR MEN) | 2% | solution · topical | P AND L | Over-the-counter | 5 Apr 1996 |
| MINOXIDIL (FOR MEN) | 2% | solution · topical | AUROBINDO PHARMA LTD | Over-the-counter | 28 Feb 1997 |
| MINOXIDIL (FOR WOMEN) | 2% | solution · topical | AUROBINDO PHARMA LTD | Over-the-counter | 28 Feb 1997 |
| ROGAINE EXTRA STRENGTH (FOR MEN) | 5% | solution · topical | KENVUE BRANDS | Over-the-counter | 14 Nov 1997 |
| MINOXIDIL (FOR MEN) | 2% | solution · topical | L PERRIGO CO | Over-the-counter | 30 Jul 1999 |
| MINOXIDIL (FOR WOMEN) | 2% | solution · topical | L PERRIGO CO | Over-the-counter | 30 Jul 1999 |
| MINOXIDIL EXTRA STRENGTH (FOR MEN) | 5% | solution · topical | P AND L | Over-the-counter | 17 Nov 2000 |
| MINOXIDIL EXTRA STRENGTH (FOR MEN) | 5% | solution · topical | PERRIGO | Over-the-counter | 13 Jun 2001 |
| MINOXIDIL EXTRA STRENGTH (FOR MEN) | 5% | solution · topical | AUROBINDO PHARMA LTD | Over-the-counter | 27 Feb 2003 |
| THEROXIDIL | 5% | solution · topical | PURE SOURCE | Over-the-counter | 24 Aug 2004 |
| MEN'S ROGAINE | 5% | aerosol, foam · topical | KENVUE BRANDS | Over-the-counter | 20 Jan 2006 |
| WOMEN'S ROGAINE | 5% | aerosol, foam · topical | KENVUE BRANDS | Over-the-counter | 20 Jan 2006 |
| THEROXIDIL | 2% | solution · topical | PURE SOURCE | Over-the-counter | 9 Nov 2007 |
| MINOXIDIL | 5% | aerosol, foam · topical | PERRIGO PHARMA INTL | Over-the-counter | 28 Apr 2011 |
| MINOXIDIL (FOR MEN) | 5% | aerosol, foam · topical | P AND L | Over-the-counter | 17 Feb 2017 |
| MINOXIDIL (FOR WOMEN) | 5% | aerosol, foam · topical | P AND L | Over-the-counter | 17 Feb 2017 |
| MINOXIDIL (FOR MEN) | 5% | aerosol, foam · topical | TARO | Over-the-counter | 31 Dec 2018 |
| MINOXIDIL (FOR WOMEN) | 5% | aerosol, foam · topical | TARO | Over-the-counter | 31 Dec 2018 |
22 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| HAIR REGROWTH FORMULA | 02356597 | 20 MG / ML | SOLUTION · TOPICAL | VITA HEALTH PRODUCTS INC |
| LONITEN 10MG | 00514500 | 10 MG | TABLET · ORAL | PFIZER CANADA ULC |
| LONITEN 2.5MG | 00514497 | 2.5 MG | TABLET · ORAL | PFIZER CANADA ULC |
| MEN'S GLN-MINOXIDIL | 02553465 | 5 % / W/W | AEROSOL (FOAM) · TOPICAL | GLENMARK PHARMACEUTICALS CANADA INC. |
| MEN'S HAIR REGROWTH TREATMENT | 02551446 | 5 % / W/W | AEROSOL (FOAM) · TOPICAL | TARO PHARMACEUTICALS INC |
| MEN'S ROGAINE | 00708925 | 20 MG / ML | SOLUTION · TOPICAL | KENVUE CANADA INC. |
| MEN'S ROGAINE FOAM 5% | 02368684 | 5 % / W/W | AEROSOL (FOAM) · TOPICAL | KENVUE CANADA INC. |
| WOMEN'S HAIR REGROWTH TREATMENT | 02551659 | 5 % / W/W | AEROSOL (FOAM) · TOPICAL | TARO PHARMACEUTICALS INC |
| WOMEN'S ROGAINE FOAM 5% | 02424703 | 5 % / W/W | AEROSOL (FOAM) · TOPICAL | KENVUE CANADA INC. |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | MINOXIDIL 10 MG TABLET | $0.15615 | per EA | 23 Sep 2026 |
| US NADAC | MINOXIDIL 2.5 MG TABLET | $0.09821 | per EA | 23 Sep 2026 |
| US NADAC | MINOXIDIL 5% SOLUTION | $0.30095 | per ML | 23 Sep 2026 |
| NHS Drug Tariff | Minoxidil 10mg tablets | £30.68 | 60 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Minoxidil 2.5mg tablets | £8.88 | 60 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Minoxidil 5% foam | £25.94 | 60 gram | 1 Oct 2026 |
| NHS Drug Tariff | Minoxidil 5% foam | £39.71 | 120 gram | 1 Oct 2026 |
| NHS Drug Tariff | Minoxidil 5% foam | £59.68 | 180 gram | 1 Oct 2026 |
| NHS Drug Tariff | Minoxidil 5mg tablets | £20.44 | 60 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 14 Jan 2026 MEN'S ROGAINE — safety-related labeling change
Labeling sections changed: Warnings and Precautions - US FDA 14 Jan 2026 ROGAINE (FOR MEN) — safety-related labeling change
Labeling sections changed: Warnings and Precautions - US FDA 14 Jan 2026 ROGAINE (FOR WOMEN) — safety-related labeling change
Labeling sections changed: Warnings and Precautions - US FDA 14 Jan 2026 ROGAINE EXTRA STRENGTH (FOR MEN) — safety-related labeling change
Labeling sections changed: Warnings and Precautions - US FDA 14 Jan 2026 WOMEN'S ROGAINE — safety-related labeling change
Labeling sections changed: Warnings and Precautions - EMA PRAC 31 Aug 2023 PRAC signal: Hypertrichosis in children following accidental exposure via patients
Action for MAH: update of the product information: No
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.